ID   C23/11
AC   CVCL_A5YN
SY   C-23/11
DR   Wikidata; Q107113527
RX   CelloPub=CLPUB00607;
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=2628077;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (CelloPub=CLPUB00607).
CC   Doubling time: 16-18 hours (Note=At passage <10), 20-23 hours (Note=At 42th passage) (CelloPub=CLPUB00607).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   CelloPub=CLPUB00607;
RA   Prosser E.S.;
RT   "Studies on the production and application of monoclonal antibodies
RT   for the detection and treatment of cancer.";
RL   Thesis PhD (1991), Dublin City University, Ireland.
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer Cell Lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   PubMed=2628077; DOI=10.1042/bst0171055;
RA   Prosser E.S., Carroll K., O'Kennedy R., Clark K., Grogan L., Otridge B.;
RT   "Establishment and preliminary characterization of a new myeloma cell
RT   line, C23/11.";
RL   Biochem. Soc. Trans. 17:1055-1056(1989).
//